Pet Allergy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
241 Pages
December 2023
Region: Global
Fairfield Market Research
ID: 5901094

The global pet allergy treatment market, which generated a revenue of US$ 2.2 billion in 2024, is projected to expand at a robust CAGR of 8.12%, reaching a substantial size of US$ 3.8 billion by the end of 2031, according to Fairfield Market Research.

The global pet allergy treatment market is experiencing unprecedented growth, driven by a surge in pet ownership and heightened awareness of allergic diseases in animals. According to the publisher, the market generated a robust revenue of US$ 2.3 billion in 2024 and is forecasted to expand to a substantial size of US$ 4 billion by the end of 2031.

Rising Prevalence of Pet Allergies

Allergies in pets, including dogs and cats, have become increasingly common, causing discomfort and health issues similar to those experienced by humans. These allergies can result from various environmental factors, such as pollen, dust mites, specific foods, and more, leading to symptoms like itching, sneezing, skin irritations, and digestive problems.

Diverse Treatment Options

The global pet allergy treatment market is responding to this growing concern by offering a wide range of treatment options, including medications, allergen-specific immunotherapy, and hypoallergenic diets. As pet owners become more attuned to their pets' allergies, the market is poised to expand further to meet the demand for effective and safe solutions to alleviate pet allergy symptoms and enhance overall pet well-being.

Advancements in Veterinary Allergology

One key driver of market growth is the increasing awareness of allergic diseases in animals and advancements in veterinary allergology. Efforts to adapt methodologies and develop specific reagents for animals have led to significant progress in this field. These advancements have enabled the identification of relevant allergens and a deeper understanding of the pathogenesis of allergic diseases in animals, such as dogs and horses.

High Demand in the United States

The United States is witnessing substantial growth in the demand for pet allergy treatment, driven by the increasing adoption of pet health insurance and the high prevalence of pet allergies. With up to 20% of all dogs expected to develop allergies during their lifetime, the need for effective treatment options is evident.

China's Rising Market

In China, the surge in pet ownership, coupled with the development of smart AI devices for pets and increased awareness of pet health, is contributing to the growing demand for pet allergy treatment. As pets in China are exposed to airborne pollutants and allergens due to poor air quality, the need for effective treatment options is on the rise.

Germany's Advanced Market

Germany's diverse climate and environmental conditions have led to a higher prevalence of allergies in pets, making it a key market for pet allergy treatment providers. The country's advanced veterinary healthcare system facilitates early diagnosis and effective treatment, attracting pet owners willing to invest in their pets' well-being.

Key Players in the Market

Prominent companies in the pet allergy treatment market include

Zoetis Animal Healthcare
Merck and Co Inc.
Boehringer Ingelheim GmbH
Elanco Animal Health Incorporated
Bayer AG
Vetoquinol S.A.
Dechra Pharmaceuticals PLC
Virbac SA
IDEXX Laboratories, Inc.
Ceva Santé Animale
Kindred Biosciences, Inc.
Phirbo Animal Health
Norbrook Laboratories Limited
Vetiquinol SA
Neogen Corporation
PetIQ, Inc.
Huvepharma AD
Chanelle Pharma Group Limited
Kepro
Biogénesis Bagó

Key Segments of Pet Allergy Treatment Industry Research

By Drug Class:

Antihistamines
Corticosteroids
Immunotherapy
Antibiotics

By Indication:

Allergic Dermatitis
Food Allergy
Fleabite Allergy
Contact Allergy

By Pet Type:

Dogs
Cats
Rodents & Rabbits

By Route of Administration:

Oral
Injectable
Topical

By Distribution Channel:

Veterinary Hospitals
Retail Pharmacies
Online Pharmacies
Others

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Pet Allergy Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Pet Allergy Treatment Market Outlook, 2018 - 2031

3.1. Global Pet Allergy Treatment Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Antihistamines
3.1.1.2. Corticosteroids
3.1.1.3. Immunotherapy
3.1.1.4. Antibiotics
3.2. Global Pet Allergy Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Allergic Dermatitis
3.2.1.2. Food Allergy
3.2.1.3. Fleabite Allergy
3.2.1.4. Contact Allergy
3.3. Global Pet Allergy Treatment Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Dogs
3.3.1.2. Cats
3.3.1.3. Rodents & Rabbits
3.4. Global Pet Allergy Treatment Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Oral
3.4.1.2. Injectable
3.4.1.3. Topical
3.5. Global Pet Allergy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. Veterinary Hospitals
3.5.1.2. Retail Pharmacies
3.5.1.3. Online Pharmacies
3.5.1.4. Others
3.6. Global Pet Allergy Treatment Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.6.1. Key Highlights
3.6.1.1. North America
3.6.1.2. Europe
3.6.1.3. Asia Pacific
3.6.1.4. Latin America
3.6.1.5. Middle East & Africa

4. North America Pet Allergy Treatment Market Outlook, 2018 - 2031

4.1. North America Pet Allergy Treatment Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Antihistamines
4.1.1.2. Corticosteroids
4.1.1.3. Immunotherapy
4.1.1.4. Antibiotics
4.2. North America Pet Allergy Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Allergic Dermatitis
4.2.1.2. Food Allergy
4.2.1.3. Fleabite Allergy
4.2.1.4. Contact Allergy
4.3. North America Pet Allergy Treatment Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Dogs
4.3.1.2. Cats
4.3.1.3. Rodents & Rabbits
4.4. North America Pet Allergy Treatment Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Oral
4.4.1.2. Injectable
4.4.1.3. Topical
4.5. North America Pet Allergy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. Veterinary Hospitals
4.5.1.2. Retail Pharmacies
4.5.1.3. Online Pharmacies
4.5.1.4. Others
4.5.2. BPS Analysis/Market Attractiveness Analysis
4.6. North America Pet Allergy Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.6.1. Key Highlights
4.6.1.1. U.S. Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
4.6.1.2. U.S. Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
4.6.1.3. U.S. Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
4.6.1.4. U.S. Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
4.6.1.5. U.S. Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.6.1.6. Canada Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
4.6.1.7. Canada Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
4.6.1.8. Canada Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
4.6.1.9. Canada Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
4.6.1.10. Canada Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.6.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Pet Allergy Treatment Market Outlook, 2018 - 2031

5.1. Europe Pet Allergy Treatment Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Antihistamines
5.1.1.2. Corticosteroids
5.1.1.3. Immunotherapy
5.1.1.4. Antibiotics
5.2. Europe Pet Allergy Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Allergic Dermatitis
5.2.1.2. Food Allergy
5.2.1.3. Fleabite Allergy
5.2.1.4. Contact Allergy
5.3. Europe Pet Allergy Treatment Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Dogs
5.3.1.2. Cats
5.3.1.3. Rodents & Rabbits
5.4. Europe Pet Allergy Treatment Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Oral
5.4.1.2. Injectable
5.4.1.3. Topical
5.5. Europe Pet Allergy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Veterinary Hospitals
5.5.1.2. Retail Pharmacies
5.5.1.3. Online Pharmacies
5.5.1.4. Others
5.5.2. BPS Analysis/Market Attractiveness Analysis
5.6. Europe Pet Allergy Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.6.1. Key Highlights
5.6.1.1. Germany Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
5.6.1.2. Germany Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.3. Germany Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.6.1.4. Germany Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.5. Germany Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.6. U.K. Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
5.6.1.7. U.K. Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.8. U.K. Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.6.1.9. U.K. Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.10. U.K. Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.11. France Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
5.6.1.12. France Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.13. France Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.6.1.14. France Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.15. France Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.16. Italy Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
5.6.1.17. Italy Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.18. Italy Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.6.1.19. Italy Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.20. Italy Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.21. Turkey Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
5.6.1.22. Turkey Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.23. Turkey Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.6.1.24. Turkey Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.25. Turkey Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.26. Russia Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
5.6.1.27. Russia Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.28. Russia Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.6.1.29. Russia Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.30. Russia Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.31. Rest of Europe Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
5.6.1.32. Rest of Europe Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
5.6.1.33. Rest of Europe Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
5.6.1.34. Rest of Europe Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.35. Rest of Europe Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pet Allergy Treatment Market Outlook, 2018 - 2031

6.1. Asia Pacific Pet Allergy Treatment Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Antihistamines
6.1.1.2. Corticosteroids
6.1.1.3. Immunotherapy
6.1.1.4. Antibiotics
6.2. Asia Pacific Pet Allergy Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Allergic Dermatitis
6.2.1.2. Food Allergy
6.2.1.3. Fleabite Allergy
6.2.1.4. Contact Allergy
6.3. Asia Pacific Pet Allergy Treatment Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Dogs
6.3.1.2. Cats
6.3.1.3. Rodents & Rabbits
6.4. Asia Pacific Pet Allergy Treatment Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Oral
6.4.1.2. Injectable
6.4.1.3. Topical
6.5. Asia Pacific Pet Allergy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. Veterinary Hospitals
6.5.1.2. Retail Pharmacies
6.5.1.3. Online Pharmacies
6.5.1.4. Others
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.6. Asia Pacific Pet Allergy Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.6.1. Key Highlights
6.6.1.1. China Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
6.6.1.2. China Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.3. China Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.6.1.4. China Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.5. China Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.6. Japan Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
6.6.1.7. Japan Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.8. Japan Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.6.1.9. Japan Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.10. Japan Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.11. South Korea Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
6.6.1.12. South Korea Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.13. South Korea Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.6.1.14. South Korea Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.15. South Korea Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.16. India Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
6.6.1.17. India Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.18. India Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.6.1.19. India Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.20. India Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.21. Southeast Asia Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
6.6.1.22. Southeast Asia Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.23. Southeast Asia Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.6.1.24. Southeast Asia Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.25. Southeast Asia Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.26. Rest of Asia Pacific Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
6.6.1.27. Rest of Asia Pacific Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
6.6.1.28. Rest of Asia Pacific Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
6.6.1.29. Rest of Asia Pacific Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.30. Rest of Asia Pacific Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pet Allergy Treatment Market Outlook, 2018 - 2031

7.1. Latin America Pet Allergy Treatment Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Antihistamines
7.1.1.2. Corticosteroids
7.1.1.3. Immunotherapy
7.1.1.4. Antibiotics
7.2. Latin America Pet Allergy Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
7.2.1.1. Allergic Dermatitis
7.2.1.2. Food Allergy
7.2.1.3. Fleabite Allergy
7.2.1.4. Contact Allergy
7.3. Latin America Pet Allergy Treatment Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Dogs
7.3.1.2. Cats
7.3.1.3. Rodents & Rabbits
7.4. Latin America Pet Allergy Treatment Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Oral
7.4.1.2. Injectable
7.4.1.3. Topical
7.5. Latin America Pet Allergy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Veterinary Hospitals
7.5.1.2. Retail Pharmacies
7.5.1.3. Online Pharmacies
7.5.1.4. Others
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.6. Latin America Pet Allergy Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.6.1. Key Highlights
7.6.1.1. Brazil Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
7.6.1.2. Brazil Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
7.6.1.3. Brazil Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
7.6.1.4. Brazil Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.6.1.5. Brazil Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.1.6. Mexico Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
7.6.1.7. Mexico Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
7.6.1.8. Mexico Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
7.6.1.9. Mexico Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.6.1.10. Mexico Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.1.11. Argentina Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
7.6.1.12. Argentina Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
7.6.1.13. Argentina Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
7.6.1.14. Argentina Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.6.1.15. Argentina Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.1.16. Rest of Latin America Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
7.6.1.17. Rest of Latin America Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
7.6.1.18. Rest of Latin America Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
7.6.1.19. Rest of Latin America Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.6.1.20. Rest of Latin America Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pet Allergy Treatment Market Outlook, 2018 - 2031

8.1. Middle East & Africa Pet Allergy Treatment Market Outlook, by Drug Class, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Antihistamines
8.1.1.2. Corticosteroids
8.1.1.3. Immunotherapy
8.1.1.4. Antibiotics
8.2. Middle East & Africa Pet Allergy Treatment Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Allergic Dermatitis
8.2.1.2. Food Allergy
8.2.1.3. Fleabite Allergy
8.2.1.4. Contact Allergy
8.3. Middle East & Africa Pet Allergy Treatment Market Outlook, by Pet Type, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Dogs
8.3.1.2. Cats
8.3.1.3. Rodents & Rabbits
8.4. Middle East & Africa Pet Allergy Treatment Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Oral
8.4.1.2. Injectable
8.4.1.3. Topical
8.5. Middle East & Africa Pet Allergy Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. Veterinary Hospitals
8.5.1.2. Retail Pharmacies
8.5.1.3. Online Pharmacies
8.5.1.4. Others
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.6. Middle East & Africa Pet Allergy Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.6.1. Key Highlights
8.6.1.1. GCC Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
8.6.1.2. GCC Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
8.6.1.3. GCC Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
8.6.1.4. GCC Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.6.1.5. GCC Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.6. South Africa Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
8.6.1.7. South Africa Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
8.6.1.8. South Africa Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
8.6.1.9. South Africa Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.6.1.10. South Africa Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.11. Egypt Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
8.6.1.12. Egypt Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
8.6.1.13. Egypt Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
8.6.1.14. Egypt Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.6.1.15. Egypt Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.16. Nigeria Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
8.6.1.17. Nigeria Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
8.6.1.18. Nigeria Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
8.6.1.19. Nigeria Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.6.1.20. Nigeria Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.21. Rest of Middle East & Africa Pet Allergy Treatment Market by Drug Class, Value (US$ Bn), 2018 - 2031
8.6.1.22. Rest of Middle East & Africa Pet Allergy Treatment Market by Indication, Value (US$ Bn), 2018 - 2031
8.6.1.23. Rest of Middle East & Africa Pet Allergy Treatment Market by Pet Type, Value (US$ Bn), 2018 - 2031
8.6.1.24. Rest of Middle East & Africa Pet Allergy Treatment Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.6.1.25. Rest of Middle East & Africa Pet Allergy Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Species vs by Indication Heat map
9.2. Manufacturer vs by Indication Heat map
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Zoetis Animal Healthcare
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Merck and Co.Inc. (US)
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Boehringer Ingelheim GmbH
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Elanco Animal Health Incorporated
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Bayer AG
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Vetoquinol S.A.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Dechra Pharmaceuticals PLC
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Virbac SA
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. IDEXX Laboratories, Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Ceva Santé Animale
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Kindred Biosciences, Inc.
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Phirbo Animal Health
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Norbrook Laboratories Limited
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Vetiquinol SA
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Neogen Corporation
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. PetIQ, Inc.
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
9.5.17. Huvepharma AD
9.5.17.1. Company Overview
9.5.17.2. Product Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
9.5.18. Chanelle Pharma Group Limited
9.5.18.1. Company Overview
9.5.18.2. Product Portfolio
9.5.18.3. Financial Overview
9.5.18.4. Business Strategies and Development
9.5.19. Kepro
9.5.19.1. Company Overview
9.5.19.2. Product Portfolio
9.5.19.3. Financial Overview
9.5.19.4. Business Strategies and Development
9.5.20. Biogénesis Bagó
9.5.20.1. Company Overview
9.5.20.2. Product Portfolio
9.5.20.3. Financial Overview
9.5.20.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

Zoetis Animal Healthcare
Merck and Co.Inc. (US)
Boehringer Ingelheim GmbH
Elanco Animal Health Incorporated
Bayer AG
Vetoquinol S.A.
Dechra Pharmaceuticals PLC
Virbac SA
IDEXX Laboratories, Inc.
Ceva Santé Animale
Kindred Biosciences, Inc.
Phirbo Animal Health
Norbrook Laboratories Limited
Vetiquinol SA
Neogen Corporation
PetIQ, Inc.
Huvepharma AD
Chanelle Pharma Group Limited
Kepro
Biogénesis Bagó

Methodology

LOADING...